Levonorgestrel-Containing Combined Oral Contraceptives for Acne
For acne treatment in women requiring contraception, use a combined oral contraceptive containing 20 mcg ethinyl estradiol and 100 mcg levonorgestrel, taken continuously for at least 6 cycles, as this regimen significantly reduces inflammatory and total acne lesions while improving biochemical markers of androgenicity. 1
Recommended Regimen
The evidence supports the following specific approach:
- Formulation: 20 mcg ethinyl estradiol + 100 mcg levonorgestrel
- Duration: Minimum 6 cycles (28 days each) to see significant improvement 1
- Mechanism: Works by lowering bioavailable androgens, which reduces sebum production and inflammatory lesions
This low-dose formulation demonstrated statistically significant reductions in both inflammatory and total lesion counts compared to placebo, with improvements in clinician global assessments and patient self-assessments (P <0.05) 1. The combination of levonorgestrel with ethinyl estradiol is superior to levonorgestrel alone for acne treatment, as the combined formulation significantly decreased both serum free testosterone and acne severity scores 2.
Positioning in Treatment Algorithm
Per the 2024 AAD guidelines, combined oral contraceptive pills receive a conditional recommendation for acne management 3. However, they serve as an important systemic option for women with persistent acne, particularly to reduce reliance on repeated or prolonged antibiotic courses 4.
COCs should be combined with topical therapies (benzoyl peroxide and/or topical retinoids) rather than used as monotherapy, following the guideline's good practice statement about combining therapies with multiple mechanisms of action 3.
Comparative Effectiveness
Among levonorgestrel-containing COCs, the evidence hierarchy shows:
- Ethinyl estradiol/levonorgestrel is more effective than placebo but slightly less effective than ethinyl estradiol/cyproterone or ethinyl estradiol/drospirenone 5
- However, it remains as effective as ethinyl estradiol/norethindrone and superior to placebo 5
Critical Contraindications to Screen For
Before prescribing, absolutely exclude:
- Migraine with aura (absolute contraindication to combined hormonal contraceptives) 6
- Current or history of thromboembolic disease
- Pregnancy or suspected pregnancy
- Breast cancer or other estrogen-sensitive malignancies
- Uncontrolled hypertension
- Smoking in women ≥35 years old
- Hepatic dysfunction or tumors
Adjunct Acne Therapies to Combine
Following the 2024 AAD guidelines' strong recommendations 3:
First-line topical combinations:
- Benzoyl peroxide (strongly recommended) + topical retinoid (adapalene, tretinoin, or tazarotene - strongly recommended)
- This addresses multiple acne pathways: comedolysis, antibacterial effects, and anti-inflammatory properties
If topical antibiotics are needed:
- Combine with benzoyl peroxide (never use antibiotics as monotherapy due to resistance concerns)
- Limit duration to ≤3 months 4
- Clindamycin is the preferred topical antibiotic
Conditionally recommended adjuncts:
- Topical azelaic acid (anti-inflammatory and antibacterial)
- Topical salicylic acid (keratolytic)
- Intralesional corticosteroids for larger nodular lesions 3
Important Caveats and Pitfalls
Age considerations: Younger women (~24 years) using levonorgestrel-containing contraceptives show higher acne incidence rates (19.3%) 7, though this data primarily relates to levonorgestrel-releasing intrauterine devices rather than COCs. The combined oral formulation with ethinyl estradiol mitigates this androgenic effect.
Progestin-only formulations: Levonorgestrel alone (without estrogen) is not recommended for acne treatment, as it lacks the anti-androgenic benefits and may worsen acne 2. The levonorgestrel intrauterine device (52 mg) shows a 19.5% acne incidence rate 7.
Timeline expectations: Counsel patients that improvement takes 3-6 cycles; acne may initially worsen before improving. Serum free testosterone levels decrease progressively during treatment 1.
Pregnancy prevention: While treating acne, maintain strict pregnancy prevention counseling, as many acne medications (particularly isotretinoin) are teratogenic.
When to escalate: If acne is severe, causing scarring, or creating significant psychosocial burden, oral isotretinoin is strongly recommended rather than prolonging COC trials 3.